US agency responds to criticismof reimbursement decisions
This article was originally published in Clinica
In response to growing criticism from industry, the US Care Financing Administration (HCFA), is considering producing guidance documents to help it make coverage decisions on new medical technologies and procedures for Medicare, the federal health insurance plan for the elderly.
You may also be interested in...
The three names under consideration also have a history of focusing on helping underprivileged communities get access to health care.
With operations in the MENA region already tracking to $700m in revenues for 2020, Hikma is looking to grow the business further after beginning negotiations with GSK to buy certain of the originator’s businesses in Egypt and Tunisia.
A safety study of Pfizer's anchor immunology brand Xeljanz showed higher rates of heart attacks and cancer versus a TNF inhibitor.